caprylates has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blakney, AK; Daniel, S; Kis, Z; Ly, HH; Soriano, SKV | 1 |
| Ferraresso, F; Juang, LJ; Kastrup, CJ; Luyendyk, JP; Poole, LG; Strilchuk, AW | 1 |
| Andres, KL; Kleinschmidt, SE; Krisko, RM; Longnecker, MP; Olsen, GW; Porter, AK; Reusch, CN; Taiwo, OA | 1 |
| Ji, J; Jian, L; Jiang, F; Li, J; Li, K; Li, T; Song, L; Wang, J; Yan, H; Yang, Z; Yu, L; Zheng, J | 1 |
4 other study(ies) available for caprylates and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach.
Topics: Amino Alcohols; Caprylates; COVID-19; Decanoates; Humans; Liposomes; Nanoparticles; RNA, Messenger; RNA, Small Interfering | 2022 |
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
Topics: Amino Alcohols; Animals; Caprylates; Cations; COVID-19; Decanoates; Hepatic Stellate Cells; Hepatocytes; Lipids; Liposomes; Mice; Nanoparticles; RNA, Small Interfering; SARS-CoV-2 | 2022 |
Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.
Topics: Alkanesulfonic Acids; Antibodies, Neutralizing; Antibody Formation; Caprylates; COVID-19; COVID-19 Vaccines; Environmental Pollutants; Fluorocarbons; Follow-Up Studies; Humans; Immunoglobulin G; Sulfonic Acids | 2022 |
Association between urinary per- and poly-fluoroalkyl substances and COVID-19 susceptibility.
Topics: Alkanesulfonic Acids; Caprylates; Case-Control Studies; China; Chromatography, Liquid; COVID-19; Environmental Pollutants; Fluorocarbons; Humans; Pandemics; RNA, Viral; SARS-CoV-2; Tandem Mass Spectrometry | 2021 |